文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > 【医脉通
侵权投诉

【医脉通

Meeting Review

MULTIPLE

JOURNAL

Multiple Sclerosis Journal19(10) 1371 –1380© The Author(s) 2012Reprints and permissions:

sagepub.co.uk/journalsPermissions.navDOI: 10.1177/1352458512471092msj.sagepub.com

A guide to facilitate the early

treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)

WM Carroll1, T Saida2, HJ Kim3, J Kira4, AG Kermode1, CP Tsai5, K Fujihara6, S Kusunoki7, M Tanaka8, KK Kim9 and D Bates10

Abstract

Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.Keywords

Multiple sclerosis, neuromyelitis optica, diagnosis, Asia, interferon beta

Date received: 25th May 2012; revised: 23rd October 2012; accepted: 4th November 2012

Introduction

Inflammatory demyelinating diseases include conditions such as multiple sclerosis (MS) and neuromyelitis optica (NMO). Diagnosis is difficult because of the clinical over-lap, particularly in the early stages, seen across the various presentations. Diagnosis is further compounded by geo-graphic disparities in disease prevalence. For example, MS is less prevalent in Asia than in the West.1 Consequently, there are fewer MS specialists per capita, reducing patient access to those who can best diagnose their symptoms. Although NMO is most prevalent in Asia, cases occur in the rest of the world.2–5

It is well-established that early treatment in MS offers the best chance of slowing the accumulation of neuro-logical damage that leads to permanent, disabling injury.6–14 It is self-evident that early events in NMO are often severely disabling. However, current treatment guidelines require definitive diagnoses which may require time and risk disease progression, and definitive diagnoses often cannot be made during the early stages of inflammatory demyelinating disease. We seek to provide a guide to facilitate the early introduction of appropriate therapy during this period of diagnostic uncertainty to

optimize long-term patient outcome. From here on, we use the term ‘idiopathic inflammatory demyelinating dis-ease’ to refer to such patients in whom a definitive diag-nosis is not possible.

Even during this period of diagnostic uncertainty, it is important to initiate the appropriate treatment early to optimize long-term patient outcome. While first-line

1Sir Charles Gairdner Hospital, Australia.

2Kansai Multiple Sclerosis Center, Kyoto, Japan. 3National Cancer Center, South Korea. 4Kyushu University, Japan. 5 Taipei Veterans General Hospital, Taiwan; National Yang-Ming University, Taiwan. 6 Tohoku University Graduate School of Medicine, Japan. 7Kinki University School of Medicine, Japan. 8Utano National Hospital, Japan.

9University of Ulsan College of Medicine, South Korea.

【医脉通

10Newcastle upon Tyne Hospitals NHS Trust, UK.

Corresponding author:

William Carroll, Department of Neurology, Sir Charles Gairdner Hospital, Verdun Street, Nedlands, WA 6009, Australia Email: carrollw@bigpond.com

第1页

你可能喜欢

热门文档

相关文档

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。心电与循环 2014 年第 33 卷第 6 期 欧美肺动脉高压诊疗指南解读郭航远 郭航远 , 浙江 大学 绍兴 医院 (绍兴 市人民...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。2015 ADA /EASD 2 型糖尿病管理指南概要(编译) 2015.1.28 近年随着降糖药物种类增多,临床医生在选择与应用降糖药物方面存...

  • 【医脉通

    【医脉通_基础医学_医药卫生_专业资料。网络出版时间:2014-12-04 16:57 网络...骨髓间充质干细胞移植对胆道缺血性狭窄的防治作用研究[J].中国普 通外科杂志,...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。临床指南中国原发性肺癌诊疗规范( 2015 年版)一、概述(一)前言 原发性肺癌 (以下简称肺癌)是我国最常见的恶性肿瘤之一。...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。中华妇幼临床医学杂志 ( 电子版 )201 4年1 2 月第 10 卷第 6期 ·733· · 标准 · 方案 · 指南 · 儿童过敏...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。主堡』L型盘查!!!篁!旦筮!!鲞筮!翅垦!i!』里型堕!,』!!!盟!Q!!:∑!!:!!:塑!:! .标准.方案.指南. 儿童...

  • 【医脉通指南频道】2014+胸痛规范化评估与诊断中国专家...

    医脉通临床指南 http://guide.medlive.cn/ 胸痛规范化评估与诊断中国专家共识胸痛是一种常见的临床症状,病因繁杂,涉及多个器官和系统,病情程度轻重不一,规范 化...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料。D 6 专题 2014 年 12 月 4 日 星期四 计, 2013 年报告的丙肝患者超 20 万, 较 2005 年增加约 3 倍。而大部分...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料 暂无评价0人阅读0次下载举报文档 【医脉通_临床医学_医药卫生_专业资料。中国实用外科杂志 2015 年 1 月第 35 卷...

  • 【医脉通

    【医脉通_临床医学_医药卫生_专业资料 暂无评价0人阅读0次下载举报文档 【医脉通_临床医学_医药卫生_专业资料。< W $3 G/ 1T " FG@ G7 , < 7 "...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email